Paasa Logo
Fuji Pharma Co., Ltd. logo
4554JPXMarket closedOpens 9:00am JST

Fuji Pharma Co., Ltd.

¥1,831.00Last updated
-¥2.00 (0.11%)Past day
Timezone

Fuji Pharma Co., Ltd. (JPX: 4554) is trading at ¥1,831.00, about ₹1,115 at today's JPY/INR rate, as of 25 Sep 2026, 2:30 AM ET, down 0.11% today. Indian residents can buy Fuji Pharma from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:¥1,835.00
Previous close:¥1,833.00
Volume:93.40K

Today's low

¥1,822.00

Today's high

¥1,848.00

52 week low

¥1,478.00

52 week high

¥2,559.00

4554 opened at ¥1,835.00, closed previously at ¥1,833.00, and has traded between ¥1,478.00 and ¥2,559.00 over the past 52 weeks.

About

Fuji Pharma Co., Ltd. is a pharmaceutical company that operates globally, focusing on the complete spectrum of drug development, from initial research and discovery through manufacturing and commercialization. Its comprehensive product line includes various medical solutions such as injectable medications, oral therapeutics, topical treatments, and a range of diagnostic tools. Beyond its core pharmaceutical offerings, Fuji Pharma also specializes in women's healthcare products, advanced in vitro diagnostic technologies, and acute medical intervention solutions. The company further contributes by disseminating valuable pharmaceutical and general health information. Founded in 1965, Fuji Pharma Co., Ltd. has its corporate headquarters located in Tokyo, Japan.

Country
JP
CEO
Shuhei Morita
Exchange listed on
JPX
Industry
Drug Manufacturers - Specialty & Generic
Base currency
JPY
Full Time Employees
1,760
Sector
Healthcare
IPO date
22/02/2010

Key statistics

Avg. volume

124.25K

Market cap

¥47.83B

P/E Ratio

15.39

Price-to-sales ratio

0.80

Enterprise value

¥66.77B

Free cash flow yield

7.99%

Debt-to-equity ratio

0.56

Return on equity

6.04%

ROIC

7.39%

Beta

0.32

Dividend yield

2.65%

Last dividend

¥48.50

Financial overview

Revenue

¥51.68B

Earnings per share

¥122.93

Free cash flow

¥3.82B

Net profit margin

4.97%

Gross margin

39.39%

EBITDA

¥8.96B

Revenue growth

12.01%

Similar securities

This is not an investment recommendation

How to buy Fuji Pharma from India

Indian residents can buy Fuji Pharma shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.

  3. Search for Fuji Pharma and place an order

    Find Fuji Pharma by name or by its ticker, 4554, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. Fuji Pharma trades 5:30 am – 12:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Fuji Pharma position in JPY and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.

Read the full guide: how to invest in Fuji Pharma from India

Trading and taxes when buying Fuji Pharma from India

Trading and limits

Trading hours
9:00 am – 3:30 pm JST
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Fuji Pharma’s current yield is 2.65%.Dividend tax explained
Estate or inheritance tax
May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Fuji Pharma stock?

Yes. Fuji Pharma (4554) has been listed on the Tokyo Stock Exchange since 2010, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Fuji Pharma share cost in rupees?

One Fuji Pharma share is ¥1,831.00 — about ₹1,115 at a JPY/INR rate of 0.6089 on 25 Sep 2026. Both the Fuji Pharma price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Fuji Pharma from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

What is the minimum I can buy of Fuji Pharma?

The Tokyo Stock Exchange typically trades in units of 100 shares.

How are gains on Fuji Pharma shares taxed in India?

Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the Fuji Pharma price. Paasa issues a capital-gains statement for your return.

Does Fuji Pharma pay a dividend, and how is it taxed in India?

Yes. Fuji Pharma pays a dividend and the current yield is 2.65%; the last declared dividend was ¥48.50 per share, about ₹29.53. Dividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.

When can I trade Fuji Pharma from India?

The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.

Is there estate or inheritance tax on Fuji Pharma shares held from India?

Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.

Do I have to declare Fuji Pharma shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Fuji Pharma holding, its cost and its closing value.

How do I sell Fuji Pharma and bring the money back to India?

You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.